Interested In Supplying, Via Direct Contracting, The Following Strategic Health Input: Ibrutinib Concentration: 140 Mg; Fulvestrant Dosage: 50 Mg/Ml Pharmaceutical Form: Injectable Solution Additional Characteristics 1: Filled Syringe; Abemaciclib Concentration: 150 Mg; Dupilumab Concentration: 150 Mg/Ml Pharmaceutical Form: Injectable Solution Additional: Filled Syringe; Ribociclib Composition: Succinate Concentration: 200 Mg; Trastuzumab Composition: Deruxtecan Concentration: 100 Mg Pharmaceutical Form: Injectable Lyophilized Powder; Nintedanib Composition: Esylate Salt Concentration: 100 Mg; Nintedanib Composition: Esylate Salt Concentration: 150 Mg; Pirfenidone Concentration: 267 Mg; Evolocumab Concentration: 140 Mg/Ml, Pharmaceutical Form: Injectable Solution, Additional: With Applicator Pen; Dupilumab Concentration: 150 Mg/Ml, Pharmaceutical Form: Injectable Solution, Additional: Prefilled Syringe; Apalutamide Concentration: 60 Mg; Ibrutinib Concentration: 420 Mg; Riociguat Concentration: 2.5 Mg; Goserelin Acetate Dosage: 10.80 Mg, Indication: Injectable Solution; Medicinal Extract Active Ingredient: Cannabidiol Oil, Concentration: 20 Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Canabidiol Prati-Donaduzzi 20 Mg/Ml, 30 Ml; Ustekinumab Concentration: 5 Mg/Ml, Pharmaceutical Form: Injectable Solution; Omalizumab Concentration: 150 Mg, Pharmaceutical Form: Injectable; Nintedanib Composition: Esylate Salt Concentration: 150 Mg; Trastuzumab Composition: Deruxtecan Concentration: 100 Mg Pharmaceutical Form: Injectable Lyophilized Powder; Degarelix Composition: Acetate Salt Concentration: 80 Mg Pharmaceutical Form: Lyophilized Powder For Injection Additional Characteristics: With Application System And Lacosamide Concentration: 200 Mg And Children'S Diet Indication: From 3 Years Old, Physical Aspect: Powder, Use: Enteral Or Oral, Protein Source: Caseinate, Carbohydrate Source: Maltodextrin And/Or Sucrose, Lipid Source: Vegetable Oils, Additional Components: Vitam